Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee.
(2015) In Bone Marrow Transplantation 50(3). p.321-323
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4908413
- author
- Chabannon, C ; Hildebrandt, M ; Scheding, Stefan LU ; Humpe, A ; Lowdell, M and Slaper-Cortenbach, I
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Bone Marrow Transplantation
- volume
- 50
- issue
- 3
- pages
- 321 - 323
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:25501349
- wos:000351632000001
- scopus:84938414967
- pmid:25501349
- ISSN
- 1476-5365
- DOI
- 10.1038/bmt.2014.271
- language
- English
- LU publication?
- yes
- id
- e845dc7e-c48f-48e6-8c9d-28a1c0444b93 (old id 4908413)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25501349?dopt=Abstract
- date added to LUP
- 2016-04-01 10:03:45
- date last changed
- 2022-07-28 19:31:51
@misc{e845dc7e-c48f-48e6-8c9d-28a1c0444b93,
author = {{Chabannon, C and Hildebrandt, M and Scheding, Stefan and Humpe, A and Lowdell, M and Slaper-Cortenbach, I}},
issn = {{1476-5365}},
language = {{eng}},
number = {{3}},
pages = {{321--323}},
publisher = {{Nature Publishing Group}},
series = {{Bone Marrow Transplantation}},
title = {{Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee.}},
url = {{http://dx.doi.org/10.1038/bmt.2014.271}},
doi = {{10.1038/bmt.2014.271}},
volume = {{50}},
year = {{2015}},
}